🇺🇸 FDA
Patent

US 9616107

Therapy for kidney disease and/or heart failure

granted A61KA61K38/2242A61K47/18

Quick answer

US patent 9616107 (Therapy for kidney disease and/or heart failure) held by Capricor Therapeutics, Inc. expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Capricor Therapeutics, Inc.
Grant date
Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/2242, A61K47/18, A61K9/0019, A61P